Clinical Trials
Sustained Release Lidocaine for the Treatment of Postoperative Pain - Clinical Trial
ST-CP-201-Sustained Release Lidocaine for the Treatment of Postoperative Pain
The ST-CP-201 Clinical trial is being conducted in subjects that are scheduled for pelvic surgery (inguinal incision, circumcision, scrotal surgery or hemorrhoidectomy). The study is being conducted at 2 centers in Vancouver and is expected to enroll approximately 60 participants. The purpose of the study is to determine if a single injection of ST-01 is safe and effective in reducing post-operative pain and opioid use as compared to a control group who receive the current standard of care.
Find a Location
ST-CP-201-Sustained Release Lidocaine for the Treatment of Postoperative Pain
British Columbia
Vancouver Prostate Centre
Vancouver, British Columbia, Canada, V5Z 1M9
Contact: Clinical Trials Coordinator, 604-875-4111 ext. 67898
Principal Investigator: Ryan Flannigan, MD
Department of Surgery,
St. Paul’s Hospital
Vancouver, British Columbia, Canada V6Z 1Y6
Contact: ST-CP-201 Study, Clinical Trials Coordinator
604-682-2344 ext. 66040
mobermayer@providencehealth.bc.ca
Principal Investigator: Dr. Amandeep Ghuman